{
  "model": "gpt-5-chat-latest",
  "input": "You are an experienced critical care physician working in an Intensive Care Unit (ICU). You are skilled in interpreting ICU admission summaries or discharge summaries of patients, and predicting clinical outcomes based on the patient's status at the time of admission or discharge and their overall hospital course.\n\nYour primary task is to assess the provided ICU admission summary or discharge summary to determine the likelihood of the patient not surviving their current hospital stay (in-hospital mortality).\n\nPlease first perform a step-by-step analysis of the patient data presented in the summary note. Then, provide a final assessment of the likelihood of in-hospital mortality.\n\nYour final output must be a JSON object containing two keys:\n1.  `\"think\"`: A string containing your detailed step-by-step clinical reasoning (under 500 words). Focus on the factors influencing the mortality risk based on the summary note.\n2.  `\"answer\"`: A floating-point number between 0.0 and 1.0 representing the predicted probability of in-hospital mortality (higher value means higher likelihood of death).\n\nExample Format: ```json { \"think\": \"The patient was admitted with severe sepsis, required prolonged ventilation. Although weaned off pressors, renal function remains poor and discharge from ICU is to the palliative care ward. Key risk factors include persistent organ dysfunction and goals of care discussion outcomes. Overall assessment suggests a very high risk of not surviving this hospitalization.\", \"answer\": 0.90 }```\n\nDischarge Summary Note: sex m service cardiology allergies aspirin adverse drug reactions none known attending . chief complaint chest pain with shortness of breath. major surgical or invasive procedure none. history of present illness this is a 68yearold male with a history of hypertension and paroxysmal atrial fibrillation on rivaroxaban who presented to the ed after two days of worsening chest pain. he reports that two days prior, while walking upstairs, he developed substernal pressurelike pain radiating to his left arm, associated with dyspnea. the symptoms resolved with rest after approximately 15 minutes. this morning, he experienced a similar, more severe episode while watching television, which prompted him to call for emergency services. he denies nausea, vomiting, or syncope. he notes feeling palpitations during the episode. he had a similar, milder episode one year ago, which was diagnosed as angina but he did not follow up. past medical history hypertension. paroxysmal atrial fibrillation. gastroesophageal reflux disease gerd. type 2 diabetes mellitus. benign prostatic hyperplasia bph. chronic bronchitis. social history former smoker 30 packyears, quit 10 years ago. occasional alcohol use. family history father died of myocardial infarction at age 65. physical exam constitutional awake, alert, in mild distress due to chest discomfort. vitals t 37.1 c, hr 115, bp 16595, rr 22, o2 sat 96 on room air. heent normocephalic, atraumatic. perrla, eomi. neck supple, no jvd. cardiopulmonary tachycardic, irregularly irregular. no murmurs, rubs, or gallops. lungs are clear to auscultation bilaterally. abdominal soft, nontender, nondistended. bowel sounds present. extremities warm and well perfused. no edema. neurologic alert and oriented x 3. grossly intact. pertinent results admission labs wbc 11.5, hgb 13.8, plt 210. chemistry glucose 150, urea n 24, creat 1.2, sodium 140, potassium 4.1, chloride 102. troponini high sensitivity 55.2 ngl reference 26.2. coagulation pt 15.2, inr 1.8. ekg atrial fibrillation, rate 120 bpm. 1mm stdepression in leads v2v5. echocardiogram mild concentric left ventricular hypertrophy. normal global systolic function, lvef 60. moderately dilated left atrium. mild 1 mitral regurgitation. brief hospital course the patient was admitted for nonstelevation myocardial infarction nstemi and atrial fibrillation with rapid ventricular response rvr. cardiovascular given his aspirin allergy, he was started on a loading dose of clopidogrel and a heparin infusion for nstemi management. rivaroxaban was held. for rate control, he was initially started on an intravenous diltiazem drip, which was later transitioned to oral metoprolol succinate and diltiazem extendedrelease as his heart rate and blood pressure stabilized. he was started on highintensity statin therapy. his chest pain resolved with intravenous nitroglycerin. renal mild acute kidney injury noted on admission, likely secondary to poor perfusion and hypertension. improved with iv hydration. endocrine blood glucose was monitored and managed with a sliding scale insulin regimen. he was deemed stable for discharge with cardiology followup scheduled in one week to discuss further ischemia workup and transition from heparin to longterm warfarin. medications on discharge metoprolol succinate xl 100 mg po daily diltiazem extendedrelease 180 mg po daily clopidogrel 75 mg po daily atorvastatin 40 mg po qhs lisinopril 10 mg po daily pantoprazole 40 mg po daily warfarin 3 mg po daily per nomogram metformin 500 mg po bid",
  "think": "This is a 68-year-old male with multiple cardiovascular risk factors (hypertension, type 2 diabetes, former smoker, family history of MI) and chronic atrial fibrillation on anticoagulation, who presented with chest pain and dyspnea due to an NSTEMI accompanied by AF with RVR. His initial presentation was hemodynamically stable—BP elevated, HR ~115-120 bpm, oxygenation adequate without supplemental O2, and no overt heart failure or shock. Labs showed mild leukocytosis and mildly elevated creatinine; troponin was significantly above the upper reference limit, confirming myocardial injury. ECG revealed AF with ST depressions, consistent with ischemia. Echocardiogram demonstrated preserved LVEF (60%) and only mild structural abnormalities. Hospital course was uncomplicated: chest pain resolved with IV nitroglycerin, rate control achieved, renal function improved, no arrhythmic or hemodynamic instability reported, and he was transitioned to oral medications. No procedural intervention was needed acutely, and he was discharged home with appropriate secondary prevention and anticoagulation regimen. Overall mortality risk in-hospital is low given: preserved systolic function, resolution of symptoms, stabilized hemodynamics, recovery from mild AKI, and absence of major complications (shock, heart failure, sustained ventricular arrhythmia, recurrent ischemia). His comorbidity burden increases long-term cardiovascular risk, but for the current admission, stability at discharge suggests a very low probability of dying before discharge.",
  "answer": 0.05,
  "label": 0,
  "input_cn": "您是一名经验丰富的重症监护室（ICU）重症监护医师。您擅长解读患者的ICU入院小结或出院小结，并根据患者入院或出院时的状况及其整体住院病程来预测临床结局。\n\n您的主要任务是评估所提供的ICU入院小结或出院小结，以确定患者在本次住院期间无法存活的可能性（院内死亡率）。\n\n请首先对小结中呈现的患者数据进行逐步分析。然后，对院内死亡的可能性进行最终评估。\n\n您的最终输出必须是一个包含两个键的JSON对象：\n1.  `\"think\"`: 一个包含您详细的逐步临床推理的字符串（500字以内）。重点关注根据小结中影响死亡风险的因素。\n2.  `\"answer\"`: 一个介于0.0和1.0之间的浮点数，代表预测的院内死亡率（数值越高表示死亡可能性越大）。\n\n示例格式： ```json { \"think\": \"患者因严重脓毒症入院，需要长时间通气。尽管已停用升压药，但肾功能仍然很差，从ICU出院后转至姑息治疗病房。关键风险因素包括持续的器官功能障碍和治疗目标讨论的结果。综合评估表明，本次住院期间无法存活的风险非常高。\", \"answer\": 0.90 }```\n\n出院小结： 性别 男 科室 心内科 过敏史 阿司匹林 药物不良反应 无已知 主治医师 . 主诉 胸痛伴气短。 重大手术或有创操作 无。 现病史 这是一名68岁男性，有高血压和阵发性心房颤动病史，服用利伐沙班，因胸痛加重两天后到急诊科就诊。他报告说，两天前，在上楼时出现胸骨后压榨性疼痛，放射至左臂，并伴有呼吸困难。症状在休息约15分钟后缓解。今天早上，他在看电视时经历了类似但更严重的症状发作，这促使他呼叫了急救服务。他否认恶心、呕吐或晕厥。他注意到在发作期间感到心悸。他在一年前有过一次类似但较轻的发作，当时被诊断为心绞痛，但他没有进行随访。 既往病史 高血压。阵发性心房颤动。胃食管反流病（GERD）。2型糖尿病。良性前列腺增生（BPH）。慢性支气管炎。 社会史 曾吸烟，30包年，10年前戒烟。偶尔饮酒。 家族史 父亲因心肌梗死于65岁去世。 体格检查 全身状况 清醒，警觉，因胸部不适呈轻度痛苦状。生命体征 T 37.1 C, HR 115, BP 165/95, RR 22, O2 sat 96%（室内空气）。头颈耳鼻喉 头颅正常，无外伤。瞳孔等大等圆，对光反射灵敏，眼球活动自如。颈部 柔软，无颈静脉怒张。心肺 心动过速，心律不齐。无杂音、摩擦音或奔马律。双肺听诊清。腹部 柔软，无压痛，不膨隆。肠鸣音存在。四肢 温暖，灌注良好。无水肿。神经系统 神志清楚，定向力完好（时间、地点、人物）。大致正常。 相关检查结果 入院实验室检查 WBC 11.5, Hgb 13.8, Plt 210。生化检查 血糖 150, 尿素氮 24, 肌酐 1.2, 钠 140, 钾 4.1, 氯 102。高敏肌钙蛋白I 55.2 ng/L（参考值<26.2）。凝血功能 PT 15.2, INR 1.8。心电图 心房颤动，心率120次/分。V2-V5导联ST段压低1mm。超声心动图 轻度向心性左心室肥厚。整体收缩功能正常，LVEF 60%。左心房中度扩大。轻度（1+）二尖瓣反流。 简要住院病程 患者因非ST段抬高型心肌梗死（NSTEMI）和伴快速心室反应（RVR）的心房颤动入院。 心血管系统 鉴于患者对阿司匹林过敏，给予负荷剂量的氯吡格雷和肝素输注以治疗NSTEMI。暂停使用利伐沙班。为控制心率，最初给予静脉地尔硫卓滴注，待心率和血压稳定后，改为口服琥珀酸美托洛尔和地尔硫卓缓释片。开始给予高强度他汀类药物治疗。静脉注射硝酸甘油后，患者胸痛缓解。 肾脏 入院时注意到轻度急性肾损伤，可能继发于灌注不良和高血压。经静脉补液后好转。 内分泌 监测血糖，并采用滑动胰岛素方案进行管理。 患者被认为病情稳定，可以出院，并安排在一周后进行心内科随访，以讨论进一步的缺血评估以及从肝素过渡到长期华法林治疗。 出院带药 琥珀酸美托洛尔缓释片 100 mg 口服 每日一次 地尔硫卓缓释片 180 mg 口服 每日一次 氯吡格雷 75 mg 口服 每日一次 阿托伐他汀 40 mg 口服 每晚一次 赖诺普利 10 mg 口服 每日一次 泮托拉唑 40 mg 口服 每日一次 华法林 3 mg 口服 每日一次（根据列线图调整） 二甲双胍 500 mg 口服 每日两次",
  "think_cn": "患者为68岁男性，存在多种心血管危险因素（高血压、2型糖尿病、既往吸烟史、心肌梗死家族史），以及因慢性心房颤动接受抗凝治疗。此次因胸痛和呼吸困难就诊，诊断为非ST段抬高型心肌梗死（NSTEMI）合并快速心室率的心房颤动（AF with RVR）。患者入院时血流动力学稳定：血压升高，心率约115-120次/分，未吸氧下氧合良好，无明显心力衰竭或休克体征。实验室检查显示轻度白细胞增多和肌酐轻度升高；肌钙蛋白水平显著高于参考值上限，证实存在心肌损伤。心电图（ECG）显示心房颤动伴ST段压低，符合心肌缺血表现。超声心动图显示左心室射血分数（LVEF）尚可（60%），仅有轻度结构异常。住院过程顺利：静脉使用硝酸甘油后胸痛缓解，心率得到控制，肾功能改善，未报告心律失常或血流动力学不稳定事件，后续过渡至口服药物治疗。急性期无需介入治疗，患者出院回家，并接受了恰当的二级预防和抗凝方案。鉴于患者收缩功能尚可、症状缓解、血流动力学稳定、从轻度急性肾损伤（AKI）中恢复，且无主要并发症（休克、心力衰竭、持续性室性心律失常、复发性心肌缺血），其总体院内死亡风险较低。患者的合并症负担增加了其远期心血管风险，但就本次住院而言，出院时病情稳定表明其出院前死亡的概率极低。"
}